Stock OXGBE GLOL BIOE
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

GLOL BIOE Stock Swiss Exchange

Equities

OXGBE

FR0011052257

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
Other stock markets
- EUR - Intraday chart for GLOL BIOE
Apr. 09 Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant MT
Mar. 06 Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2023 8.91M 9.68M Sales 2024 * 1.75M 1.9M Capitalization 33.4M 36.29M
Net income 2023 -8M -8.69M Net income 2024 * -6M -6.52M EV / Sales 2023 4.1 x
Net cash position 2023 * 1.8M 1.96M Net Debt 2024 * 16.4M 17.82M EV / Sales 2024 * 28.5 x
P/E ratio 2023
-4.21 x
P/E ratio 2024 *
-2.39 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 84.03%
More Fundamentals * Assessed data

Latest news about GLOL BIOE

Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant MT
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Global Bioenergies Partners with Shell on More Focused Development of Low-carbon Road Fuels MT
Global Bioenergies SA Announces Board Changes CI
Global Bioenergies: financial visibility extended CF
Global Bioenergies Hires Chief Business Officer MT
Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer CI
Global Bioenergies Secures EUR16 Million Government Funding for Biosourced Isobutene Plant MT
Global Bioenergies: disappointment after half-year results CF
Global Bioenergies SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Global Bioenergies Launches Isonaturane® 16, Its Second Cosmetic Ingredient CI
Global markets live: Blackberry, Meta Platforms, Rivian, GM... Our Logo
Global Bioenergies: capital increase, share price falls CF
Global markets live: Airbus, Walmart, Meta, Home Depot... Our Logo
Global Bioenergies: research contract extended with Shell CF
More news

Analyst Recommendations on GLOL BIOE

Global Bioenergies : Invest Securities initiates ALGBE stock research coverage with a buy recommendation PU
Global Bioenergies : INVEST SECURITIES INITIATES ALGBE STOCK RESEARCH COVERAGE WITH A BUY RECOMMENDATION GL
Global Bioenergies : BAADER BANK INITIATES ALGBE STOCK RESEARCH COVERAGE WITH A BUY RECOMMENDATION GL
More recommendations

Press releases GLOL BIOE

Global Bioenergies ISO 9001 certified GL
Global Bioenergies ISO 9001 certified AQ
Global Bioenergies has received letters of intent for its plant project corresponding to forecasted annual sales of over €70 million GL
Global Bioenergies has received letters of intent for its plant project corresponding to forecasted annual sales of over €70 million AQ
Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity GL
More press releases

News in other languages on GLOL BIOE

Global Bioenergies publie son Document d’enregistrement universel 2023
Global Bioenergies certifiée ISO 9001
On s'occupe comme on peut
En Direct des Marchés : EsssilorLuxottica, Bouygues, Atos, BioMérieux, UBS, Eli Lilly, L'Occitane...
Global Bioenergies a reçu des lettres d’intention pour son projet d’usine correspondant à un chiffre d’affaires annuel projeté de plus de 70 millions d’euros
More news

Managers and Directors - GLOL BIOE

Managers TitleAgeSince
Marc Delcourt FOU
 Founder 53 08-10-05
Samuel Dubruque DFI
 Director of Finance/CFO - 13-12-31
Frédéric Ollivier CTO
 Chief Tech/Sci/R&D Officer - 19-08-31
Members of the board TitleAgeSince
Pierre Levi BRD
 Director/Board Member 69 19-04-17
Marc Delcourt FOU
 Founder 53 08-10-05
Jean-Claude Lumaret BRD
 Director/Board Member 66 Jan. 17
More insiders

Company Profile

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-09-17 - Q2 2024 Earnings Release (Projected)
More about the company

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.91% 227B
DANAHER CORPORATION Stock Danaher Corporation
+15.46% 198B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.58% 142B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.36% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.34% 64.16B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+17.74% 54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+5.82% 51.41B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+11.23% 45.32B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+5.73% 37.32B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ALGBE Stock
  4. OXGBE Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW